Literature DB >> 17632790

Ataxia-telangiectasia: mild neurological presentation despite null ATM mutation and severe cellular phenotype.

Neora Alterman1, Aviva Fattal-Valevski, Lilach Moyal, Thomas O Crawford, Howard M Lederman, Yael Ziv, Yosef Shiloh.   

Abstract

Ataxia-telangiectasia (A-T) is an autosomal recessive disorder characterized by progressive neurodegeneration, immunodeficiency, susceptibility to cancer, genomic instability, and sensitivity to ionizing radiation. A-T is caused by mutations that eliminate or inactivate the nuclear protein kinase ATM, the chief activator of the cellular response to double strand breaks (DSBs) in the DNA. Mild A-T is usually caused by ATM mutations that leave residual amounts of active ATM. We studied two siblings with mild A-T, as defined by clinical examination and a quantitative A-T neurological index. Surprisingly, no ATM was detected in the patients' cells, and sequence analysis revealed that they were homozygous for a truncating ATM mutation (5653delA) that is expected to lead to the classical, severe neurological presentation. Moreover, the cellular phenotype of these patients was indistinguishable from that of classical A-T: all the tested parameters of the DSB response were severely defective as in typical A-T. This analysis shows that the severity of the neurological component of A-T is determined not only by ATM mutations but also by other influences yet to be found. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17632790     DOI: 10.1002/ajmg.a.31853

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  14 in total

1.  Homozygosity for c 6325T>G transition in the ATM gene causes an atypical, late-onset variant form of ataxia-telangiectasia.

Authors:  Gabriella Silvestri; Marcella Masciullo; Maria Piane; Camilla Savio; Anna Modoni; Massimo Santoro; Luciana Chessa
Journal:  J Neurol       Date:  2010-05-18       Impact factor: 4.849

Review 2.  An update on inherited ataxias.

Authors:  Tanja Schmitz-Hübsch; Thomas Klockgether
Journal:  Curr Neurol Neurosci Rep       Date:  2008-07       Impact factor: 5.081

3.  Variant ataxia-telangiectasia presenting as primary-appearing dystonia in Canadian Mennonites.

Authors:  R Saunders-Pullman; D Raymond; A J Stoessl; D Hobson; K Nakamura; T Nakamura; S Pullman; D Lefton; M S Okun; R Uitti; R Sachdev; K Stanley; M San Luciano; J Hagenah; R Gatti; L J Ozelius; S B Bressman
Journal:  Neurology       Date:  2012-02-15       Impact factor: 9.910

Review 4.  Ataxia-telangiectasia - A historical review and a proposal for a new designation: ATM syndrome.

Authors:  Hélio A G Teive; Adriana Moro; Mariana Moscovich; Walter O Arruda; Renato P Munhoz; Salmo Raskin; Tetsuo Ashizawa
Journal:  J Neurol Sci       Date:  2015-05-29       Impact factor: 3.181

5.  Stable brain ATM message and residual kinase-active ATM protein in ataxia-telangiectasia.

Authors:  Jiali Li; Jianmin Chen; Harry V Vinters; Richard A Gatti; Karl Herrup
Journal:  J Neurosci       Date:  2011-05-18       Impact factor: 6.167

6.  Autosomal recessive adult onset ataxia.

Authors:  Nataša Dragašević-Mišković; Iva Stanković; Andona Milovanović; Vladimir S Kostić
Journal:  J Neurol       Date:  2021-09-09       Impact factor: 4.849

7.  Cytoplasmic ATM in neurons modulates synaptic function.

Authors:  Jiali Li; Yu R Han; Mark R Plummer; Karl Herrup
Journal:  Curr Biol       Date:  2009-12-03       Impact factor: 10.834

8.  Mutations in String/CDC25 inhibit cell cycle re-entry and neurodegeneration in a Drosophila model of Ataxia telangiectasia.

Authors:  Stacey A Rimkus; Rebeccah J Katzenberger; Anthony T Trinh; Gerald E Dodson; Randal S Tibbetts; David A Wassarman
Journal:  Genes Dev       Date:  2008-04-11       Impact factor: 11.361

9.  Individual Cytokines Modulate the Neurological Symptoms of ATM Deficiency in a Region Specific Manner

Authors:  Chin Wai Hui; Karl Herrup
Journal:  eNeuro       Date:  2015-08-18

Review 10.  Ataxia telangiectasia: a review.

Authors:  Cynthia Rothblum-Oviatt; Jennifer Wright; Maureen A Lefton-Greif; Sharon A McGrath-Morrow; Thomas O Crawford; Howard M Lederman
Journal:  Orphanet J Rare Dis       Date:  2016-11-25       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.